| CV Therapeutics, Inc. (CVT), headquartered in Palo Alto, California, is a biopharmaceutical company focused on the discovery, development, and commercialization of new small molecule drugs for the treatment of cardiovascular diseases. They apply advances in molecular biology and genetics to identify mechanisms of cardiovascular diseases and targets for drug discovery. |